Danish drugmaker Novo Nordisk A/S said on Monday it is terminating a recently formed obesity-drug partnership with Hims & ...

The mass rollout of weight loss jabs such as Mounjaro on the NHS in England will begin today as GPs are allowed to prescribe the drugs for the ...

Research shows that increased fruit consumption is associated with reduced abdominal fat in children, highlighting its ...

Novo Nordisk A/S is terminating a recently formed obesity-drug partnership with Hims & Hers Health Inc. that had been touted ...

The aggregate gross proceeds to the Company of this offering are expected to be approximately $2.0 million, before deducting the offering expenses payable by the Company. The Company currently intends ...

MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery and development of ...

Toby Nicol, CEO at CheqUp, said: “We welcome the NHS making Mounjaro available, but the reality is that it will remain out of ...

Novo Nordisk, the maker of popular weight loss drugs Wegovy and Ozempic, did not immediately provide detailed reasons for ...

“The medication comes with a patient information leaflet listing common side effects, including feeling sick, indigestion, ...

Majority of UK children will be overweight or obese in nine areas by 2035 - Nine worst affected areas predicted to see child ...

Baron Funds, an investment management company, released its “Baron Fifth Avenue Growth Fund” first quarter 2025 investor ...